Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates. by Alexandra Anderson (97972)

“…<p>Adult wild type animals were exposed to <i>M. nematophilum</i> on plates containing exogenous serotonin and the Dar phenotype was scored in their progeny. Treatment with 3.8 mg/ml 5-HT caused a 35% decrease in the number of Dar animals following <i>M. nematophilum</i> infection using standard assay conditions (small lawn) (A). …”

Sulpiride decreases anterior pituitary cell proliferation <i>in vivo</i>. by Jimena Ferraris (314722)

FLZ decreased the expression of BACE1 and did not affect the expression of IDE. by Xiu-Qi Bao (479278)

Decreased s.c. growth of CNDT 2.5 cells after systemic administration of DOPC liposome-conjugated siNRP-2. by Shaija Samuel (341436)

“…Nude mice (7 per group) were s.c. injected with 1×10⁶ CNDT 2.5 cells. Mice with visible tumors were stratified and treated with 5 µg of liposome-conjugated siRNA (i.p. injections) twice weekly. …”

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Association between CVR components^b'*' and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Baseline characteristics of the study participants. by Sandra Martín-Peláez (11353470)

Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

The effect of Mdivi-1 administration on cell apoptosis in vivo. by Dong Ma (584680)

U87MG cells present decreased viability after HJURP silencing. by Valeria Valente (78411)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Detailed meta–analyses in untreated hypothyroid patients compared with controls for each HRV parameters: RR intervals, SDNN, RMSSD, pNN50, TP, LF, HF, LF/HF. by Valentin Brusseau (12769704)

The basic characteristics of the included studies. by Junyin Pan (20700411)

Subjects:

Common definitions and criteria for metabolic syndrome. by Junyin Pan (20700411)

Subjects:

Assessment of study bias in the included research. by Junyin Pan (20700411)

Subjects:

Results of the effect of dietary anthocyanins on health outcomes, including effect size and heterogeneity analysis. by Junyin Pan (20700411)

Subjects:

Risk of bias assessment for eligible randomized controlled trials. by Junyin Pan (20700411)

Subjects:

Summary of studies identified in the literature search, including studies excluded from the analysis and reasons for exclusion. by Junyin Pan (20700411)

Subjects:

The flow chart of study selection process. by Junyin Pan (20700411)

Subjects:

Data extracted from included studies for the systematic review and meta-analysis. by Junyin Pan (20700411)

Subjects: